Point72 Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,026,749
| Closed | -$8.53M | – | 1583 |
|
|
2024
Q3 | $8.53M | Sell |
1,026,749
-2,492,812
| -71% | -$20.7M | 0.02% | 531 |
|
|
2024
Q2 | $25.2M | Buy |
3,519,561
+2,109,199
| +150% | +$15.1M | 0.07% | 314 |
|
|
2024
Q1 | $12.2M | Buy |
1,410,362
+459,162
| +48% | +$3.98M | 0.03% | 543 |
|
|
2023
Q4 | $6.23M | Buy |
+951,200
| New | +$6.23M | 0.02% | 682 |
|
|
2023
Q3 | – | Sell |
-460,111
| Closed | -$5.72M | – | 2028 |
|
|
2023
Q2 | $5.72M | Buy |
+460,111
| New | +$5.72M | 0.02% | 642 |
|
|
2022
Q4 | – | Sell |
-151,000
| Closed | -$3.86M | – | 1310 |
|
|
2022
Q3 | $3.86M | Buy |
+151,000
| New | +$3.86M | 0.02% | 679 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1229 |
|
|
2022
Q1 | – | Sell |
-390,900
| Closed | -$16.4M | – | 1200 |
|
|
2021
Q4 | $16.4M | Buy |
390,900
+261,412
| +202% | +$11M | 0.07% | 364 |
|
|
2021
Q3 | $6.36M | Buy |
+129,488
| New | +$6.36M | 0.03% | 571 |
|
|
2021
Q1 | – | Sell |
-493,883
| Closed | -$13.9M | – | 1044 |
|
|
2020
Q4 | $13.9M | Buy |
+493,883
| New | +$13.9M | 0.07% | 349 |
|